SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Mar 5, 2019
Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: March 5, 2019 · CIK: 0001517681 · Accession: 0001493152-19-002885
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229856
Letter
PROPANC BIOPHARMA, INC.
302, 6 Butler Street
Camberwell, VIC, 3124 Australia
March 5, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F Street N.E.
Washington, D.C. 20549
Re: Propanc Biopharma, Inc.
Registration Statement on Form S-1
File No. 333-229856
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be accelerated so that it will become effective at 12:00 P.M. Eastern Standard Time on Thursday, March 7, 2019, or as soon as practicable thereafter.
We request that we be notified of such effectiveness by a telephone call to Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465, or in his absence Sasha Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0466. We also respectfully request that a copy of the written order from the United States Securities and Exchange Commission verifying the effective time and date of such Registration Statement be sent to Foley Shechter Ablovatskiy LLP, attention: Jonathan Shechter, via facsimile at (917) 688-4092.
Sincerely,
PROPANC BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
PROPANC
BIOPHARMA, INC.
302,
6 Butler Street
Camberwell,
VIC, 3124 Australia
March
5, 2019
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street N.E.
Washington,
D.C. 20549
Re:
Propanc
Biopharma, Inc.
Registration
Statement on Form S-1
File
No. 333-229856
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby requests
that the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”)
be accelerated so that it will become effective at 12:00 P.M. Eastern Standard Time on Thursday, March 7, 2019, or as soon as
practicable thereafter.
We
request that we be notified of such effectiveness by a telephone call to Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy
LLP at (212) 335-0465, or in his absence Sasha Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0466. We also
respectfully request that a copy of the written order from the United States Securities and Exchange Commission verifying the
effective time and date of such Registration Statement be sent to Foley Shechter Ablovatskiy LLP, attention: Jonathan Shechter,
via facsimile at (917) 688-4092.
Sincerely,
PROPANC BIOPHARMA, INC.
By:
/s/
James Nathanielsz
Name:
James
Nathanielsz
Title:
Chief
Executive Officer
Cc:
Jonathan
Shechter, Esq. of Foley Shechter Ablovatskiy LLP
Sasha
Ablovatskiy, Esq. of Foley Shechter Ablovatskiy LLP